Abstract
Background: Psoriasis is a cutaneous inflammatory condition characterized by an altered turnover of keratinocytes leading to scaly patches. Secukinumab and ixekizumab are two biologic drugs inhibiting interleukin-17.
Objective: We report the first case, according to Naranjo score, of a secukinumab-induced erectile dysfunction with severe plaque psoriasis that disappeared after switching to another anti IL17 drug (ixekizumab).
Methods: A 45 years old man experienced erectile dysfunction during treatment with an anti-IL17. The adverse effect appeared after 60 days of treatment with secukinumab and rapidly disappeared after discontinuation of the drug. All necessary urologic exams were carried out. Re-administration of secukinumab, due to the exacerbation of psoriasis, caused the same sexual dysfunction after 60 days.
Results: Switching to ixekizumab lead to a resolution of the erectile dysfunction and a complete skin clearance.
Conclusion: We describe for the first time a sexual dysfunction possibly due to secukinumab and its resolution after the switch to another similar but different drug, highlighting the potential difference between anti-IL17A drugs.
Keywords: Anti-IL17, psoriasis, sexual dysfunction, drug-related side effects, ixekizumab, secukinumab, naranjo Score.
[http://dx.doi.org/10.1038/nrdp.2016.82] [PMID: 27883001]
[http://dx.doi.org/10.1016/j.jaad.2018.02.027] [PMID: 29438757]
[http://dx.doi.org/10.1007/s13555-015-0092-3] [PMID: 26714681]
[http://dx.doi.org/10.1007/s40674-015-0022-7]
[http://dx.doi.org/10.1016/j.jaad.2016.03.024] [PMID: 27180926]
[http://dx.doi.org/10.1016/j.jaad.2018.01.003] [PMID: 29307635]
[http://dx.doi.org/10.1007/s40744-016-0031-5] [PMID: 27747518]
[http://dx.doi.org/10.1177/2040622317738910] [PMID: 29344327]
[http://dx.doi.org/10.1111/andr.12366] [PMID: 28622464]
[http://dx.doi.org/10.1111/jdv.14391] [PMID: 28602039]
[http://dx.doi.org/10.1016/j.jaad.2015.02.1127] [PMID: 25824273]
[http://dx.doi.org/10.1111/bjd.16140] [PMID: 29171861]
[http://dx.doi.org/10.1111/bjd.16497] [PMID: 29785816]
[http://dx.doi.org/10.1038/clpt.1981.154] [PMID: 7249508]